The rare disease world is shaped by a few key overarching issues. Individual diseases have low patient populations, this is by definition of course, but it is worth acknowledging that many conditions have fewer than 1,000 people affected in the UK. There are very few treatments for rare diseases, the European Medicines Agency has licensed … [Read more…]